US Patent 9968659 Liraglutide in cardiovascular conditions

Patent 9968659 was granted and assigned to Novo Nordisk on May, 2018 by the United States Patent and Trademark Office.

Is a

Patent Applicant

Current Assignee

Patent Jurisdiction

Patent Number

Date of Patent

May 15, 2018

Patent Application Number

15401651

Date Filed

January 9, 2017

Patent Citations Received

Patent Primary Examiner

Patent abstract

The present invention relates to the GLP-1 receptor agonist liraglutide for use in medicine.

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 9968659 Liraglutide in cardiovascular conditions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.